STENTYS Announces the Pre-Commercialization of SERPENTIS, its New Latest-Generation of Active Stent
9 November 2017
STENTYS, a medical technology company commercializing the Xposition S self-apposing coronary stent, today announces the pre-commercialization of Serpentis, its new Sirolimus-eluting stent with a bi
